Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock — Positive
BMRN Zacks Investment Research — August 28, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Broadridge Financial Solutions (BR) is a Top Growth Stock for the Long-Term — Positive
BR Zacks Investment Research — August 28, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Eversource Energy (ES) is a Top Growth Stock for the Long-Term — Positive
ES Zacks Investment Research — August 28, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why GoDaddy (GDDY) is a Strong Growth Stock — Positive
GDDY Zacks Investment Research — August 28, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Jones Lang LaSalle (JLL) is a Strong Growth Stock — Positive
JLL Zacks Investment Research — August 28, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
National Fuel Gas (NFG) is a Top-Ranked Growth Stock: Should You Buy? — Positive
NFG Zacks Investment Research — August 28, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Palomar (PLMR) is a Top Growth Stock for the Long-Term — Positive
PLMR Zacks Investment Research — August 28, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Ralph Lauren (RL) is a Strong Growth Stock — Positive
RL Zacks Investment Research — August 28, 2025Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Faruqi & Faruqi Reminds LifeMD Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 27, 2025 - LFMD — Neutral
LFMD PRNewsWire — August 28, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in LifeMD between May 7, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 28, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. ("LifeMD" or …
Atour Lifestyle reported accelerated growth in Q2, accompanied by another 2025 revenue guidance raise and fairly strong margins. Underlying hotel business metrics remain fair. The ADR has started to stabilize, but occupancy has still seen pressure from increasing competition. Growing brand recognition has continued to boost Atour's retail revenues as the company invests massively in marketing.
Tesla sales in Europe plummet 40% — while Chinese rival BYD sees sales triple — Negative
BYDDF TSLA New York Post — August 28, 2025It marked the seventh straight month of declines for Elon Musk's automaker, which has continued to suffer from brand damage, a lack of enthusiasm over newer models and intense Chinese competition.
Sweetgreen faces both internal operational challenges and external consumer headwinds, leading to weak Q2 results and a sharp stock decline. Management's new initiatives, including Project One Best Way, highlight significant operational deficiencies, with only a third of stores meeting high standards. Same-store sales are on a negative trajectory, and revised guidance points to continued declines, despite efforts to increase value and menu appeal.
Dollar General Warns About Consumer Pressures Even as It Posts Solid Results — Negative
DG Investopedia — August 28, 2025Dollar General (DG) shares slipped Thursday as concerns that low-income consumers were facing macroeconomic pressures offset news that the discount retailer beat profit and sales estimates and raised its guidance as shoppers looked for bargains.
Are Consumer Discretionary Stocks Lagging Perdoceo Education (PRDO) This Year? — Negative
PRDO Zacks Investment Research — August 28, 2025Here is how Perdoceo Education (PRDO) and Rush Street Interactive, Inc. (RSI) have performed compared to their sector so far this year.
Why Teck Resources Ltd (TECK) is a Top Value Stock for the Long-Term — Positive
TECK Zacks Investment Research — August 28, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Potbelly (PBPB) Outperforming Other Retail-Wholesale Stocks This Year? — Positive
PBPB Zacks Investment Research — August 28, 2025Here is how Potbelly (PBPB) and Red Robin (RRGB) have performed compared to their sector so far this year.
Should Value Investors Buy Prog Holdings (PRG) Stock? — Positive
PRG Zacks Investment Research — August 28, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Everest Group (EG) is a Top Value Stock for the Long-Term — Positive
EG Zacks Investment Research — August 28, 2025Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Sensata Technologies Holding (ST) Stock Undervalued Right Now? — Positive
ST Zacks Investment Research — August 28, 2025Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Has Akero Therapeutics (AKRO) Outpaced Other Medical Stocks This Year? — Positive
AKRO Zacks Investment Research — August 28, 2025Here is how Akero Therapeutics, Inc. (AKRO) and Stryker (SYK) have performed compared to their sector so far this year.
